Antifibrotic effect of aloe vera in viral infection-induced hepatic periportal fibrosis

Figure 3 Hepatic malondialdhyde and glutathione of hepatic fibrosis patients and controls. A: Hepatic malondialdhyde (μmol/g) of hepatic fibrosis patients and controls; B: Hepatic reduced glutathione (μg/g) of hepatic fibrosis patients and controls. ^aP < 0.05, ^cP < 0.05 vs before treatment and conventional group. Data are presented as mean ± SD. MDA: Malondialdehyde; GSH: Glutathione; AHM: Aloe vera high molecular weight fractions.